Suchergebnisse - "Ganzel, Chezi"

PubPharm (81)

1

Successful treatment with daratumumab of a patient with monoclonal lambda light chain disease presenting as nephrotic syndrome and crescentic glomerulonephritis

enthalten in: Acta haematologica | 2024

von Bnaya, A. | Ganzel, C. | Shavit, L.

2

Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy : a phase 2 study

enthalten in: Blood advances | 2023

von Altman, J. | Zuckerman, T. | Koprivnikar, J. | +23

3

Venetoclax-based salvage therapy for adult patients with relapsed/refractory acute lymphoblastic leukemia

enthalten in: European journal of haematology | 2023

von Canaani, J. | Frisch, A. | Pollyea, D. | +11

4

Pseudohyperkalemia in chronic lymphocytic leukemia : Prevalence, impact, and management challenges

enthalten in: The American journal of the medical sciences | 2023

von Bnaya, A. | Ganzel, C. | Shavit, L.

5

Process of drug registration in Israel : the correlation between the number of discussions within the Ministry of Health and postapproval variations by EMA and/or FDA

enthalten in: BMJ open | 2023

von Hiayev, S. | Shacham-Shmueli, E. | Berkovitch, M. | +24

6

Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma : A multicentre retrospective study

enthalten in: British journal of haematology | 2023

von Shragai, T. | Magen, H. | Lavi, N. | +19

7

Clinical features, therapy patterns, outcomes and prognostic factors of solitary plasmacytomas : a report of the Israeli Myeloma Study Group

enthalten in: Leukemia & lymphoma | 2022

von Ganzel, C. | Trestman, S. | Levi, S. | +15

8

Measurable residual disease by flow cytometry in acute myeloid leukemia is prognostic, independent of genomic profiling

enthalten in: Leukemia research | 2022

von Ganzel, C. | Sun, Z. | Baslan, T. | +15

9

NT-proBNP and High-Sensitivity Cardiac Troponin T Fail to Detect Cardiac Involvement in Erdheim-Chester Disease

enthalten in: Mayo Clinic proceedings | 2022

von Azoulay, L. | Ganzel, C. | Bravetti, M. | +4

10

Gilteritinib monotherapy for relapsed/refractory FLT3 mutated acute myeloid leukemia : a real-world, multi-center, matched analysis

enthalten in: Annals of hematology | 2022

von Shimony, S. | Canaani, J. | Kugler, E. | +12

ErratumIn: Ann Hematol. 2022 Jul 23;:. - PMID 35869985

1
2
3
4
5
6
7
8
9
Nächster »
[9]